Invitrogen Introduces Dynachip™ HLA Antibody Analysis System

Product News

Published: December 14, 2006

Want a FREE PDF version of this product news?

Complete the form below and we will email you a PDF version of "Invitrogen Introduces Dynachip™ HLA Antibody Analysis System"

First Name*

Last Name*

Email Address*

Country*

Company Type*

Job Function*

Would you like to receive further email communication from Technology Networks?

Listen with

Speechify

0:00

Thank you. Listen to this article using the player above. ✖

Read time:

Invitrogen Corporation has introduced its DynaChip™ HLA Antibody Analysis system.

DynaChip™ technology will utilize an automated microarray platform to detect antibody reaction to specific HLA antigens.

The DynaChip™ technology is developed as a result of collaboration between German array developer Clondiag, a unit of Inverness Medical Innovations, Inc., and Invitrogen.

The product is designed to perform upto 96 tests at the same time in a fully automated manner, with each test including an array of proteins.

The system includes software that can allow for rapid analysis of results. The DynaChip™ system is currently available in Europe under a CE mark and is available for ‘research use only’ in the United States.

It is in the process of obtaining FDA 510K clearance in the United States.

Drug Discovery

Drug Discovery

Invitrogen Introduces Dynachip™ HLA Antibody Analysis System